|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4000 SEK | -5.66% |
|
0.00% | +25.39% |
| 05-29 | Monivent sees MDR process progressing according to plan | FW |
| 05-18 | Monivent to continue operations following initial capital sufficiency meeting | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.82M | 3.56M | 3.57M | 2.94M | 4.53M | |||||
Other Revenues, Total | - | - | - | - | - | |||||
Total Revenues | 1.82M | 3.56M | 3.57M | 2.94M | 4.53M | |||||
Cost of Goods Sold, Total | 1.08M | 1.45M | 1.59M | 1.02M | 630K | |||||
Gross Profit | 746K | 2.11M | 1.98M | 1.92M | 3.9M | |||||
Selling General & Admin Expenses, Total | 11.11M | 15.58M | 15.2M | 12.31M | 11.66M | |||||
Depreciation & Amortization - (IS) | 1.84M | 882K | 804K | 804K | 720K | |||||
Other Operating Expenses | -1.32K | -5.49K | -151K | -20.56K | -26.72K | |||||
Other Operating Expenses, Total | 12.95M | 16.46M | 15.85M | 13.09M | 12.36M | |||||
Operating Income | -12.21M | -14.35M | -13.87M | -11.17M | -8.45M | |||||
Interest Expense, Total | -86.42K | -53.08K | -376K | -492K | -343K | |||||
Interest And Investment Income | 64.36K | 21.23K | 101K | 22.69K | 4.78K | |||||
Net Interest Expenses | -22.05K | -31.85K | -274K | -470K | -339K | |||||
Currency Exchange Gains (Loss) | -28.58K | - | -37.17K | -36.21K | -91.13K | |||||
Other Non Operating Income (Expenses) | 396 | - | - | -1 | - | |||||
EBT, Excl. Unusual Items | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
EBT, Incl. Unusual Items | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
Earnings From Continuing Operations | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
Net Income to Company | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
Net Income - (IS) | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
Net Income to Common Incl Extra Items | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
Net Income to Common Excl. Extra Items | -12.26M | -14.38M | -14.18M | -11.67M | -8.88M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -1.66 | -1.84 | -1.35 | -0.54 | -0.16 | |||||
Basic EPS - Continuing Operations | -1.66 | -1.84 | -1.35 | -0.54 | -0.16 | |||||
Basic Weighted Average Shares Outstanding | - | 7.81M | - | - | - | |||||
Net EPS - Diluted | -1.66 | -1.84 | -1.35 | -0.54 | -0.16 | |||||
Diluted EPS - Continuing Operations | -1.66 | -1.84 | -1.35 | -0.54 | -0.16 | |||||
Diluted Weighted Average Shares Outstanding | - | 7.81M | - | - | - | |||||
Normalized Basic EPS | -1.04 | -1.15 | -0.84 | -0.34 | -0.1 | |||||
Normalized Diluted EPS | -1.04 | -1.15 | -0.84 | -0.34 | -0.1 | |||||
Supplemental Items | ||||||||||
EBITDA | -11.99M | -13.46M | -13.65M | -10.96M | -8.33M | |||||
EBITA | -12.21M | -14.35M | -13.87M | -11.17M | -8.45M | |||||
EBIT | -12.21M | -14.35M | -13.87M | -11.17M | -8.45M | |||||
EBITDAR | -11.61M | - | -13.15M | -10.44M | -7.82M | |||||
Total Revenues (As Reported) | 1.82M | 3.62M | 3.72M | 2.96M | 4.56M | |||||
Normalized Net Income | -7.66M | -8.99M | -8.86M | -7.3M | -5.55M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 1.63M | - | 593K | 593K | 593K | |||||
Net Rental Expense, Total | 382K | - | 503K | 513K | 508K | |||||
Imputed Operating Lease Interest Expense | 264K | - | 1.45M | 1.42M | 810K | |||||
Imputed Operating Lease Depreciation | 118K | - | -944K | -909K | -301K | |||||
Stock-Based Comp., Other (Total) | 145K | 178K | -284K | 7.02K | -17.96K | |||||
Total Stock-Based Compensation | 145K | 178K | -284K | 7.02K | -17.96K |
- Stock Market
- Stocks
- MONI Stock
- Financials Monivent AB
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
